Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate

Pierpaolo Di Micco; Vincenzo Russo; Corrado Lodigiani

doi:10.3390/medicina56100506

Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate

Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.

Authors

Pierpaolo Di Micco¹, Vincenzo Russo², Corrado Lodigiani³

Affiliations

¹ UOC Medicina, Fatebenefratelli Hospital of Naples, 34102 Naples, Italy.
² Chair of Cardiology, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli"-Monaldi Hospital, Piazzale Ettore Ruggeri, 80131 Naples, Italy.
³ Thrombosis and Hemorrhagic Center, Humanitas Research Hospital IRCC and Humanitas University, 20089 Rozzano, Italy.

Abstract

Asreported by the World Health Organization, a novel coronavirus (COVID-19) was identified as the causative virus of new viral pneumonia of unknown etiology by Chinese authorities on 7 January 2020. The virus was named COVID-19 and because of its ability to cause severe acute respiratory syndrome (i.e., SARS) this infection has also been defined as SARS-CoV2.Furthermore, an association between COVID-19 infection and venous thromboembolism has been reported in several series around the world.For this reason, methods used to improve diagnostic tools, pharmacological thromboprophylaxis and type of anticoagulants are discussed in this expert opinion.

Keywords: COVID-19; SARS-CoV2; coronavirus; venous thromboembolism.

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use*
Betacoronavirus*
COVID-19
Coronavirus Infections / complications*
Humans
Pandemics
Pneumonia, Viral / complications*
SARS-CoV-2
Venous Thromboembolism / drug therapy*
Venous Thromboembolism / etiology*

Substances

Anticoagulants